EFTA00299745Set 9
2017-09-0815p5,255w
BioReference
LABORATORI ES FINAL REPORT
en OPKO Health Cur.peny
ER, STUART EPSTEIN, JEFFREY Specimen ID: 104364919
00B: 01/20/1553 Age: 64 V Sex: M Date Of Report: en/00/2017 1.1:34
C3070 ... edi/di.
litrlirartit- Totr e.s <1.2 . .mdidt •
.
LD 235 NI 195.225
E s • •
Cr - *fit
BioReference Laboratories, Inc.
James Weisberger M.D. Page 1 of IS
481 Edward H. Ross ... POLYS 46.9 36.0-T6S t
;OHMS . • . 39.0 .--- :54/1:9
_.. . . .
:Alois 7.7 0.0-13.0 S
.. .
BioReference Laboratories, Inc. JamosVhaisboroorbeD. Page 2 of IS
401 Edward H. Ross Dr i Elmwood Park
https://www.justice.gov/epstein/files/DataSet%209/EFTA00299745.pdf
EFTA01100382Set 9
2015-10-295p1,385w
CARDIOVASCULAR/LIPIDS *--
Cholesterol 210 HI <200 mg/dL
Triglycerides 348 HI <150 mg/dL
BioReference Laboratories, Inc. JamesiallebbeegerILD. Page 1 of 5
481 Edward H. Ross Dr I Elmwood Park ... considered sub-therapeutic
for the above conditions.
PTT 27.6 23.6-31.6 sec I
BioReference Laboratories, Inc. James Weisberger M.D. Page 2 of 5
481 Edward H. Ross Dr I Elmwood ... procedures may
be used for this purpose. Predictions of disease recurrence should not be
BioReference Laboratories, Inc. James Weisberger M.D. Page 3 of 5
481 Edward H. Ross
https://www.justice.gov/epstein/files/DataSet%209/EFTA01100382.pdf
EFTA00594095Set 9
2015-10-295p1,487w
CARDIOVASCULAR/LIPIDS *--
Cholesterol 210 HI <200 mg/dL
Triglycerides 348 HI <150 mg/dL
BioReference Laboratories, Inc. JamesWolsberger.. Page 1 of S
481 Edward H. Ross Dr I Elmwood Park ... considered sub-therapeutic
for the above conditions.
PIT 27.6 23.6-31.6 sec I [
BioReference Laboratories, Inc. JannesiNekbergerIll. Page 2 of 5
481 Edward H. Ross Dr I Elmwood Park ... procedures may
be used for this purpose. Predictions of disease recurrence should not be
BioReference Laboratories, Inc. JarnesWelsbergerIll. Page 3 of 5
481 Edward H. Ross Dr I Elmwood Park
https://www.justice.gov/epstein/files/DataSet%209/EFTA00594095.pdf
EFTA00599643Set 9
2016-01-285p1,558w
10/27/2015
-* CARDIOVASCULAR/LIPIDS *--
Cholesterol 143 <200 mg/dL 210 HI 10/27/2015
BioReference Laboratories, Inc. James Weisberger M.D. Page 1 of S
Elmwood Park, N3 07407 Labcwatory[WW0C Printed 01/28/2016 15:30
EFTA00599643 ... INTR.NORM.RATIO(INR) 0.97 LO 2.00-3.00 0.92 LO 10/27/2015
CLINICAL INDICATIONS FOR INR USE
BioReference Laboratories, Inc. JannesINeisbergerM.D. Page 2 of 5
Elmwood Park. NJ 07407 Laboratory Director printed 01/28/2016 ... Method Electrochemiluminescence Immunoassay (Roche Diagnostics)
PSA, FREE 0.33 Not Estab. ng/mL 0.31 10/27/201S
I
BioReference Laboratories, Inc. James Weisberger M.D. Page 3 of S
Elmwood Park, NJ 07407 Laboratory Director
https://www.justice.gov/epstein/files/DataSet%209/EFTA00599643.pdf
EFTA01107161Set 9
2016-01-285p1,606w
10/27/2015
-* C•'rl 0V•SCUL•'/LI•I0S *--
Cholesterol 143 <200 mg/dL 210 HI 10/27/2015
BioReference Laboratories, Inc. James Weisberger M.D. Page 1 of S
481 Edward H. Ross ... 10/27/2015
I
CLINICAL INDICATIONS FOR INR USE
BioReference Laboratories, Inc. James Weisberger M.D. Page 2 of 5
481 Edward H. Ross Dr I Elmwood Park ... Method Electrochemiluminescence Immunoassay (Roche Diagnostics)
PSA, FREE 0.33 Not Estab. ng/mL 0.31 110/27/2015
I
BioReference Laboratories, Inc. James Weisberger M.D. Page 3 of 5
481 Edward H. Ross
https://www.justice.gov/epstein/files/DataSet%209/EFTA01107161.pdf
EFTA00609801Set 9
2017-09-0415p5,129w
BioReference
LABORATORI ES FINAL REPORT
en C2FeBel:Imeaks Company
ORSHER, STUART EPSTEIN, JEFFREY Specimen ID: 104364919
DOB: 01/20/1953 Age: 64 V Sex: M Date Of Report: 09/04/2017 11:3*
- STUART ... vi/di
friliratt-Totr e.s <1.2 . mg/dt
.
LD 235 NI 195.225 U/L
ETAiss •
•
'46-134
BioReference Laboratories, Inc. James Weisberger M.D. Page 1 of 15
481 Edward H. Ross ... indicate recent or current infection, but is
--inconclusive for diagnosis. Serocorversion between acute and
BioReference Laboratories, Inc.
JarnmeMftnabersperlAIL Page 8 Of 15
481 Edward H. Ross Or I !Inwood Park
https://www.justice.gov/epstein/files/DataSet%209/EFTA00609801.pdf
EFTA00582641Set 9
2016-07-238p1,955w
01/27/2016
Evaluation: ABOVE AV6.(MODERATE RISK)
Chol/HDL Ratio 7.5 <7.4 6.0 01/27/2016
BioReference Laboratories, Inc. lames 4eisberger, Clinical Page 1 of 6
481 Edward H. Ross Dr Elmwood Park ... Glucose, Urine NEGATIVE NEGATIVE
Ketone, Urine NEGATIVE NEGATIVE
Urobilinogen Urine 0.2 0.2 - 1.0 eg/dL
BioReference Laboratories, Inc. lames Weisberger, ill. Clinical Page 2 of 6
481 Edward H. Rcss ... ZLZI. iPsid H 14:104:SO 91O2 6O End
EFTA00582647
FINAL REPORT
BioReference
LABORATORIES
D FISCH, HARRY EPSTEIN, JEFFREY s Specimen ID: 105819158
A HARRY FISCH, H.D. D00:01/20
https://www.justice.gov/epstein/files/DataSet%209/EFTA00582641.pdf
EFTA01733939Set 10
2016-07-238p2,004w
01/27/2016
Evaluation: MOVE AVG.(HODERATE RISK)
Chol/HDL Ratio 7.5 <7.4 6.0 81/27/2016
BioReference Laboratories, Inc. lames Heisberger, N.D. Clinical Page 1 of 6
481 tdward H. Ross Dr I Elmwood ... 101/27/2016
Test Not Performed: Specimen rejected for testing due to moderate or marked
BioReference Laboratories, Inc. lames Weisberger, A.D. Clinical Page 3 of 6
481 Edward N. Ross ... ng/mL and percent FREE PSA
values is sumarized in the table below:
BioReference Laboratories, Inc. lames Weisberger, N.D. Clinical Page 4 of 6
481 Edward H. Ross Dr I Elmwood
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01733939.pdf
EFTA00299765Set 9
2017-08-305p1,770w
Ii/dL. , • • "
VLDL, CALCULATED Can't Calm 7-32 mg/di (._.Can't CaLc 108/39/2017
...._... . •--
BioReference Laboratories, Inc. James Weisberger M.D. Page 1 of
481 Edward H. Ross Dr I Elammod Park ... INFORMAT/ON: Bartonella Quintana
Ab, lgm
-- Less than 1:16 Negative-No significant level of
.... . .
BioReference Laboratories, Inc.
481 Edward R. Ross Dr I Elmwood Park. NJ James Weisberger M.D. Page
https://www.justice.gov/epstein/files/DataSet%209/EFTA00299765.pdf